Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 78,108 | 227,385 | 238,816 | 252,826 | 273,737 |
| Marketable Securities | 121,324 | N/A | N/A | N/A | N/A |
| TOTAL | $204,905 | $232,614 | $243,847 | $259,294 | $281,808 |
| Non-Current Assets | |||||
| PPE Net | 24,441 | 20,369 | 19,412 | 17,902 | 15,654 |
| Investments And Advances | 4,898 | 0 | 0 | 0 | 0 |
| TOTAL | $29,340 | $20,369 | $19,412 | $17,902 | $15,654 |
| Total Assets | $234,245 | $252,982 | $263,259 | $277,196 | $297,463 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 3,556 |
| Accounts payable and accrued liabilities | 8,067 | 6,120 | 1,739 | 3,218 | 5,018 |
| Accrued Expenses | 10,221 | 7,194 | 5,991 | 4,674 | 3,146 |
| TOTAL | $18,797 | $13,643 | $7,980 | $8,094 | $11,910 |
| Non-Current Liabilities | |||||
| TOTAL | $66 | $66 | $66 | $63 | $63 |
| Total Liabilities | $18,862 | $13,708 | $8,046 | $8,157 | $11,972 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 90,125 | 90,124 | 90,122 | 90,122 | 90,122 |
| Common Shares | 9 | 9 | 9 | 9 | 9 |
| Retained earnings | -100,246 | -75,665 | -59,285 | -45,088 | -27,971 |
| Other shareholders' equity | -342 | 0 | 0 | 0 | 0 |
| TOTAL | $215,382 | $239,274 | $255,213 | $269,039 | $285,490 |
| Total Liabilities And Equity | $234,245 | $252,982 | $263,259 | $277,196 | $297,463 |